Table 2.

Effects of Multisystemic Therapy versus Telephone Support on Metabolic Control and Regimen Adherence

Time and regression model	HbA1c	DMS-Parent	DMS-Youth
7 Months post-test
Model 1
Baseline status, β1 (95% CI)	0.61 (0.49, 0.74) *	0.53 (0.41, 0.66) *	0.49 (0.36, 0.63)
Intervention condition, β2 (95% CI)	−0.98 (−1.63, −0.34) *	5.70 (1.58, 9.82) *	1.61 (−2.64, 5.86)
Model fit: R2	0.43	0.37	0.27
Model 2
Baseline measure, β1 (95% CI)	0.58 (0.44,0.73) *	0.47 (0.34, 0.60) *	0.44 (0.30, 0.58)
Intervention condition, β2 (95% CI)	−1.01 (−1.67, −0.36) *	5.72 (1.61, 9.83) *	1.54 (−2.67, 5.74)
Age (in years), β3 (95% CI)	0.05 (−0.10, 0.21)	−0.93 (−1.92, 0.05)	−0.97 (−1.94, 0.01)
Race, β4 (95% CI)	0.39 (−0.45, 1.24)	1.15 (−3.94, 6.23)	1.92 (−3.22, 7.06)
Single parent, β4(95% CI)	−0.01 (−0.70, 0.67)	2.21 (−2.12, 6.54)	0.68 (−3.82, 5.17)
Type 1 vs. type 2, β5 (95% CI)	−0.32 (−1.41, 0.76)	−2.70 (−9.50, 4.10)	−5.86 (−12.81, 1.08)
Model fit: R2	0.44	0.40	0.32
12 Months post-test
Model 1
Baseline measure, β1 (95% CI)	0.68 (0.54, 0.83) *	0.55 (0.43, 0.67) *	0.66 (0.51, 0.80)
Intervention condition, β2 (95% CI)	−0.67(−1.40, 0.07)	4.77 (0.88, 8.67) *	1.37 (−3.08, 5.83)
Model fit: R2	0.41	0.41	0.37
Model 2
Baseline measure, β1 (95% CI)	0.63 (0.47, 0.78)*	0.50 (0.38, 0.63)*	0.59 (0.43, 0.74)
Intervention condition, β2 (95% CI)	−0.74 (−1.48, −0.01)*	5.10 (1.21, 8.99)*	1.51 (−2.86, 5.88)
Age (in years), β3 (95% CI)	0.07 (−0.11, 0.24)	−0.84 (−1.74, 0.07)	−1.36 (−2.35, −0.38)
Race, β4 (95% CI)	0.39 (−0.59, 1.36)	−0.80 (−5.72, 4.12)	−0.91 (−6.48, 4.66)
Single parent, β4(95% CI)	0.06 (−0.71, 0.83)	−1.53 (−5.60, 2.53)	1.39 (−3.25, 6.03)
Type 1 vs. type 2, β5 (95% CI)	1.14 (−0.11, 2.39)	−4.55(−11.11, 2.02)	−4.43 (−11.80, 2.95)
Model fit: R2	0.43	0.44	0.42

Note. DMS= Diabetes Management Scale.

^*p < .05.